1. Home
  2. Detail

@luay_mrega:

لؤي مريقه
لؤي مريقه
Open In TikTok:
Region: ID
Thursday 15 October 2026 02:17:06 GMT
156
12
0
1

Music

Download

No Watermark .mp4 (1.11MB) No Watermark(HD) .mp4 (1.11MB) Watermark .mp4 (0MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @luay_mrega, please go to the Tikwm homepage.

Other Videos
☀🤎🌻 #غرفتي
☀🤎🌻 #غرفتي


King nasir X messi #kingnasir #messi #dance #dancing #lionelmessi
King nasir X messi #kingnasir #messi #dance #dancing #lionelmessi
Could GLP-1 drugs be anti-aging medications? The medications appear to slow the body’s aging processes, a sign that suggests they could ultimately help people live longer. The idea that these medications may extend lifespan isn’t exactly far-fetched; it’s more of an extension of what they’ve already been shown to do. Studies have found that along with helping people lose weight and control blood sugar, GLP-1 drugs improve the health of many different parts of the body, lowering the risk of heart, kidney and liver disease, for example, and reducing sleep apnea and inflammation. A recent pre-print paper from drugmaker Novo Nordisk involved measuring changes to proteins in the body over time in people using semaglutide. The company’s scientists found that it reduced the heart’s biological age by two to four years compared with a placebo, and it reduced the age of organs such as the lung, kidney, brain and pancreas by one to four years. @CNN #cnn #cnnhealth #jacquelinehoward #glp1
Could GLP-1 drugs be anti-aging medications? The medications appear to slow the body’s aging processes, a sign that suggests they could ultimately help people live longer. The idea that these medications may extend lifespan isn’t exactly far-fetched; it’s more of an extension of what they’ve already been shown to do. Studies have found that along with helping people lose weight and control blood sugar, GLP-1 drugs improve the health of many different parts of the body, lowering the risk of heart, kidney and liver disease, for example, and reducing sleep apnea and inflammation. A recent pre-print paper from drugmaker Novo Nordisk involved measuring changes to proteins in the body over time in people using semaglutide. The company’s scientists found that it reduced the heart’s biological age by two to four years compared with a placebo, and it reduced the age of organs such as the lung, kidney, brain and pancreas by one to four years. @CNN #cnn #cnnhealth #jacquelinehoward #glp1


About

Legal